http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010114192-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-815 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-815 |
| filingDate | 2008-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010114192-A |
| titleOfInvention | DEREZA AND INFLAMMATION |
| abstract | 1. The use of the primary composition, including dereza berries or parts thereof, to obtain a product for the treatment or prevention of inflammation. ! 2. The use according to claim 1, wherein the primary composition further comprises a carrier containing milk or milk protein. ! 3. The use according to one of claims 1 and 2, in which the primary composition and / or product does not contain insoluble fibers. ! 4. The use according to claim 1, in which the product is intended for oral, topical, enteral and / or parenteral use, and / or in which the product is a dietary supplement, an additive as or as part of a medicament, or an additive as or as part of cream, and / or in which the product is intended for and / or applied to humans or pets. ! 5. The use according to claim 1, in which the product is intended for human consumption in the composition or as a food product, for example, a complete nutritional mixture, a dairy product that is refrigerated or stable during storage of the product, a product for nursing mothers, a liquid drink, soup, additives to the diet, food substitute, nutrition bar, confectionery, milk or sour milk product, yogurt, milk powder, product for enteral nutrition, infant formula, infant food product, mashed potatoes, upyanogo product or a fermented cereal products, ice cream, candy, sweets, biscuits, cakes / pastries, chocolate, cappuccino, coffee, a culinary product type mayonnaise, tomato puree or salad dressings, pet food or beverage for pets. ! 6. The use according to claim 1, in which the product is a tablet, capsule, saw |
| priorityDate | 2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.